Predictors of adverse pathologic features after radical prostatectomy in low-risk prostate cancer

被引:12
作者
Park, Jae Won [1 ]
Koh, Dong Hoon [1 ]
Jang, Won Sik [1 ]
Cho, Kang Su [1 ]
Ham, Won Sik [1 ]
Rha, Koon Ho [1 ]
Hong, Sung Joon [1 ]
Choi, Young Deuk [1 ]
机构
[1] Yonsei Univ, Urol Sci Inst, Dept Urol, Coll Med, 50-1 Yonsei Ro, Seoul 120752, South Korea
关键词
Low-risk prostate cancer; Adverse pathologic features; Needle biopsy; Radical prostatectomy; ISUP CONSENSUS CONFERENCE; QUALITY-OF-LIFE; ACTIVE SURVEILLANCE; INTERNATIONAL-SOCIETY; RADIATION-THERAPY; ADJUVANT; TRENDS; RADIOTHERAPY; CRITERIA; FAILURE;
D O I
10.1186/s12885-018-4416-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Prostate-specific antigen (PSA) screening more frequently detects early stage prostate cancer (PC). However, adverse pathologic features (APFs) after radical prostatectomy (RP) in low-risk PC occur. Previous related studies had utilized outdated staging criteria or small sample cohorts. In this study, we analyzed predictors of APFs after RP in low-risk PC using classification under the current criteria. Materials and methods: We retrospectively reviewed medical records of 546 low-risk PC patients who had undergone RP. Low-risk PC was defined as PC with clinical T1-T2a, Gleason score <= 6, and PSA levels < 10 ng/mL. Clinical and pathological parameters were analyzed to predict APFs. APFs were defined as extracapsular extension (ECE), seminal vesicle invasion (SVI), or positive surgical margins (PSM). We analyzed our data using univariable and multivariable logistic regression analyses, as well as receiver operator characteristics to predict APFs. Results: Among 546 patients, ECE, SVI, and PSM were present in 199 (36.4%), 8 (1.5%), and 179 cases (32.8%), respectively. PSM had a significant correlation with preoperative high PSA levels and number of positive cores obtained. ECE/SVI was also significantly correlated with PSA levels and number of positive cores. As a result, presence of APFs after RP was associated with high PSA levels and large number of positive cores. PSA > 4.5 ng/mL and number of positive cores > 2 in low-risk PC were significantly associated with APFs, and suggested as cut-off values for predicting APFs. Conclusions: PSA > 4.5 ng/mL and number of positive cores > 2 in low-risk PC were associated with presence of APFs and patients with such records should be considered carefully to provide active surveillance.
引用
收藏
页数:7
相关论文
共 28 条
[1]   Overdiagnosis and overtreatment of early detected prostate cancer [J].
Bangma, C. H. ;
Roemeling, S. ;
Schroder, F. H. .
WORLD JOURNAL OF UROLOGY, 2007, 25 (01) :3-9
[2]   Pathologic Findings in Radical Prostatectomy Specimens From Patients Eligible for Active Surveillance With Highly Selective Criteria: A Multicenter Study [J].
Beauval, Jean-Baptiste ;
Ploussard, Guillaume ;
Soulie, Michel ;
Pfister, Christian ;
Van Agt, Simon ;
Vincendeau, Sebastien ;
Larue, Sebastien ;
Rigaud, Jerome ;
Gaschignard, Nicolas ;
Roupret, Morgan ;
Drouin, Sarah ;
Peyromaure, Mickael ;
Long, Jean Alexandre ;
Iborra, Francois ;
Vallancien, Guy ;
Rozet, Francois ;
Salomon, Laurent .
UROLOGY, 2012, 80 (03) :656-660
[3]   Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911) [J].
Bolla, Michel ;
van Poppel, Hein ;
Tombal, Bertrand ;
Vekemans, Kris ;
Da Pozzo, Luigi ;
de Reijke, Theo M. ;
Verbaeys, Antony ;
Bosset, Jean-Francois ;
van Velthoven, Roland ;
Colombel, Marc ;
van de Beek, Cees ;
Verhagen, Paul ;
van den Bergh, Alphonsus ;
Sternberg, Cora ;
Gasser, Thomas ;
van Tienhoven, Geertjan ;
Scalliet, Pierre ;
Haustermans, Karin ;
Collette, Laurence .
LANCET, 2012, 380 (9858) :2018-2027
[4]   Pathological Outcomes of Candidates for Active Surveillance of Prostate Cancer [J].
Conti, Simon L. ;
Dall'Era, Marc ;
Fradet, Vincent ;
Cowan, Janet E. ;
Simko, Jeffery ;
Carroll, Peter R. .
JOURNAL OF UROLOGY, 2009, 181 (04) :1628-1633
[5]  
Conti SL., 2009, J Urol, V181, P16281633
[6]   Contemporary trends in low risk prostate cancer: Risk assessment and treatment [J].
Cooperberg, Matthew R. ;
Broering, Jeannette M. ;
Kantoff, Philip W. ;
Carroll, Peter R. .
JOURNAL OF UROLOGY, 2007, 178 (03) :S14-S19
[7]   Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer [J].
Cooperberg, Matthew R. ;
Broering, Jeanette M. ;
Carroll, Peter R. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (07) :1117-1123
[8]   The changing face of low-risk prostate cancer: Trends in clinical presentation and primary management [J].
Cooperberg, MR ;
Lubeck, DP ;
Meni, MV ;
Mehta, SS ;
Carroll, PR .
JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (11) :2141-2149
[9]   Prognostic value of a cell cycle progression signature for prostate cancer death in a conservatively managed needle biopsy cohort [J].
Cuzick, J. ;
Berney, D. M. ;
Fisher, G. ;
Mesher, D. ;
Moller, H. ;
Reid, J. E. ;
Perry, M. ;
Park, J. ;
Younus, A. ;
Gutin, A. ;
Foster, C. S. ;
Scardino, P. ;
Lanchbury, J. S. ;
Stone, S. .
BRITISH JOURNAL OF CANCER, 2012, 106 (06) :1095-1099
[10]   Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer [J].
D'Amico, AV ;
Whittington, R ;
Malkowicz, SB ;
Schultz, D ;
Blank, K ;
Broderick, GA ;
Tomaszewski, JE ;
Renshaw, AA ;
Kaplan, I ;
Beard, CJ ;
Wein, A .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1998, 280 (11) :969-974